DOPACARD 10 Micromol Concentrate for Soln for Inf Ireland - English - HPRA (Health Products Regulatory Authority)

dopacard 10 micromol concentrate for soln for inf

cephalon limited - dopexamine hydrochloride - concentrate for soln for inf - 10 micromol

Dopacard New Zealand - English - Medsafe (Medicines Safety Authority)

dopacard

new zealand medical & scientific ltd - dopexamine hydrochloride 1%;   - solution for injection - 1 % - active: dopexamine hydrochloride 1%   excipient: disodium edetate dihydrate hydrochloric acid water for injection

DOPACARD Concentrate for Soln for Inf 10 Ireland - English - HPRA (Health Products Regulatory Authority)

dopacard concentrate for soln for inf 10

cephalon limited - dopexamine hydrochloride - concentrate for soln for inf - 10

Dopamine 800mg/5ml solution for infusion ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dopamine 800mg/5ml solution for infusion ampoules

martindale pharmaceuticals ltd - dopamine hydrochloride - solution for infusion - 160mg/1ml

Ongentys European Union - English - EMA (European Medicines Agency)

ongentys

bial - portela cª, s.a. - opicapone - parkinson disease - anti-parkinson drugs - ongentys is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.ongentys is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.